bpc-157 human clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or bpc-157 recommended dosage humans bpc
Description
While both are sterile and have similar uses, they have different indications and demographics

Piperine, the potential functional food for mood and cognitive disorders

The science in humans is close to nonexistent, so describing it as preliminary is an understatement

General Precautions: Vitamin B12 deficiency that is allowed to progress for longer than 3 months may produce permanent degenerative lesions of the spinal cord
